F. Cetani

C. Marcocci, F. Cetani, A. Pinchera, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Vitamin D measurement and effect on outcome in a cohort of patients with heart failure

C. Marcocci, F. Cetani, M. Scalese, 2018, Endocrine connections.

Abbreviations used: AD,

F. Cetani, T. Battelino, L. Tserel, 2022 .

Spontaneous short-term remission of primary hyperparathyroidism from infarction of a parathyroid adenoma

C. Marcocci, F. Cetani, A. Pinchera, 2004, Journal of endocrinological investigation.

Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor.

F. Cetani, M. Tonacchera, S. Costagliola, 1996, European journal of endocrinology.

Pseudohypoparathyroidism: focus on cerebral and renal calcifications.

C. Marcocci, F. Cetani, P. Piaggi, 2021, The Journal of clinical endocrinology and metabolism.

Renal complications and quality of life in postsurgical hypoparathyroidism: a case–control study

F. Cetani, R. Elisei, B. Cosci, 2021, Journal of Endocrinological Investigation.

Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism.

C. Marcocci, F. Cetani, J. Bilezikian, 2020, The Journal of clinical endocrinology and metabolism.

Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

C. Marcocci, F. Cetani, M. Scalese, 2019, Journal of Endocrinological Investigation.

First evidence of TRPV5 and TRPV6 channels in human parathyroid glands: possible involvement in neoplastic transformation

C. Marcocci, F. Cetani, F. Basolo, 2014, Journal of cellular and molecular medicine.

Do the heterozygous carriers of a CYP24A1 mutation display a different biochemical phenotype than wild types?

C. Marcocci, F. Cetani, F. Baldinotti, 2020, The Journal of clinical endocrinology and metabolism.

Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study

C. Marcocci, F. Cetani, M. Brandi, 2020, Orphanet Journal of Rare Diseases.

Thyrotoxicosis Systemic Manifestations

C. Marcocci, F. Cetani, 2004 .

Parathyroid Carcinoma and Ectopic Secretion of Parathyroid hormone.

C. Marcocci, F. Cetani, E. Pardi, 2021, Endocrinology and metabolism clinics of North America.

Whole exome sequencing in familial isolated primary hyperparathyroidism

C. Marcocci, F. Cetani, C. Mazzanti, 2020, Journal of Endocrinological Investigation.

Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.

C. Marcocci, F. Cetani, A. Pinchera, 2004, The Journal of clinical endocrinology and metabolism.

Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism

A. Gemignani, F. Cetani, E. Pardi, 2022, Journal of Endocrinological Investigation.

Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism

S. Giannini, A. Scarpa, F. Cetani, 2022, Nutrients.

Diagnostic, therapeutic and healthcare management protocols in parathyroid surgery: II Consensus Conference of the Italian Association of Endocrine Surgery Units (U.E.C. CLUB)

M. Pelizzo, C. Marcocci, F. Cetani, 2014, Journal of Endocrinological Investigation.

Efficacy and safety of long-term management of patients with chronic post-surgical hypoparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2018, Journal of Endocrinological Investigation.

Primary hyperparathyroidism.

C. Marcocci, F. Cetani, 1980, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

The Long Non-Coding BC200 Is a Novel Circulating Biomarker of Parathyroid Carcinoma

F. Cetani, V. Vaira, E. Pardi, 2022, Frontiers in Endocrinology.

TSH receptor and disease

F. Cetani, J. Parma, M. Tonacchera, 1996, Clinical endocrinology.

Re: Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.

C. Marcocci, F. Cetani, M. Bisceglia, 2008, Surgery.

Genetic analysis of the MEN1 gene and HPRT2 locus in two Italian kindreds with familial isolated hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Clinical endocrinology.

Development of an algorithm to predict serum vitamin D levels using a simple questionnaire based on sunlight exposure

C. Marcocci, F. Cetani, E. Vignali, 2016, Endocrine.

Assays of TSH-receptor antibodies in 576 patients with various thyroid disorders: their incidence, significance and clinical usefulness.

F. Cetani, A. Pinchera, G. Fenzi, 1989, Autoimmunity.

Parathyroid carcinoma.

F. Cetani, V. Nicastro, A. Scillitani, 2018, Best practice & research. Clinical endocrinology & metabolism.

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer

M. Rugge, M. Pelizzo, M. Papotti, 2013, Endocrine connections.

Case report: Early-onset osteoporosis in a patient carrying a novel heterozygous variant of the WNT1 gene

C. Marcocci, F. Cetani, A. Fogli, 2022, Frontiers in Endocrinology.

Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Journal of endocrinological investigation.

Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.

E. Brown, C. Marcocci, F. Cetani, 2000, The Journal of clinical endocrinology and metabolism.

No Evidence for Mutations in the Calcium‐Sensing Receptor Gene in Sporadic Parathyroid Adenomas

C. Marcocci, F. Cetani, E. Vignali, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone disease in primary hyperparathyrodism

C. Marcocci, F. Cetani, L. Cianferotti, 2012, Therapeutic advances in musculoskeletal disease.

Should parafibromin staining replace HRTP2 gene analysis as an additional tool for histologic diagnosis of parathyroid carcinoma?

C. Marcocci, F. Cetani, A. Pinchera, 2007, European journal of endocrinology.

Cinacalcet in the management of primary hyperparathyroidism: post marketing experience of an Italian multicentre group

E. Papini, C. Marcocci, F. Cetani, 2013, Clinical endocrinology.

Cinacalcet efficacy in patients with moderately severe primary hyperparathyroidism according to the European Medicine Agency prescription labeling

C. Marcocci, F. Cetani, E. Vignali, 2012, Journal of Endocrinological Investigation.

Clinical presentation and management of patients with primary hyperparathyroidism in Italy

C. Marcocci, F. Cetani, M. Brandi, 2018, Journal of Endocrinological Investigation.

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1–84) treatment

F. Cetani, G. Beccuti, L. Ghizzoni, 2021, Journal of Endocrinological Investigation.

A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases.

C. Marcocci, F. Cetani, E. Vignali, 2002, European journal of endocrinology.

Evaluation of formalin-fixed paraffin-embedded tissues in the proteomic analysis of parathyroid glands

C. Marcocci, F. Cetani, F. Basolo, 2011, Proteome Science.

Nonfunctioning Parathyroid Carcinoma

C. Marcocci, F. Cetani, 2016 .

Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.

S. Swillens, F. Cetani, J. Parma, 1996, The Journal of clinical endocrinology and metabolism.

Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors

F. Cetani, M. Tonacchera, G. Vassart, 1996, FEBS letters.

MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders.

L. Rejnmark, C. Marcocci, F. Cetani, 2019, European journal of endocrinology.

Cinacalcet in the management of primary hyperparathyroidism

C. Marcocci, F. Cetani, 2012, Expert review of endocrinology & metabolism.

Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts.

C. Marcocci, F. Cetani, G. Hendy, 2014, The Journal of clinical endocrinology and metabolism.

Specific activation of the thyrotropin receptor by trypsin

A. Allgeier, F. Cetani, J. Dumont, 1996, Molecular and Cellular Endocrinology.

A New MEN2 Syndrome with Clinical Features of Both MEN2A and MEN2B Associated with a New RET Germline Deletion

F. Cetani, A. Franchi, F. Basolo, 2020, Case reports in endocrinology.

Undetectable inferior petrosal sinus levels of PTH-related peptide (PTHrP) in patients with ACTH-dependent Cushing’s disease

Elena S. Di Martino, F. Cetani, E. Martino, 2005, Journal of endocrinological investigation.

Hypercalcemia due to CYP24A1 mutations: a systematic descriptive review.

C. Marcocci, F. Cetani, F. Baldinotti, 2021, European journal of endocrinology.

Non-surgical management of primary hyperparathyroidism.

C. Marcocci, F. Cetani, F. Saponaro, 2018, Best practice & research. Clinical endocrinology & metabolism.

Update on the use of cinacalcet in the management of primary hyperparathyroidism

C. Marcocci, F. Cetani, 2011, Journal of Endocrinological Investigation.

Expression, function, and regulation of the embryonic transcription factor TBX1 in parathyroid tumors.

F. Cetani, V. Vaira, A. Scillitani, 2017, Laboratory investigation; a journal of technical methods and pathology.

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database

G. Gronchi, C. Marcocci, F. Cetani, 2017, Endocrine.

Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2

F. Cetani, R. Elisei, C. Romei, 2012, Journal of oncology.

Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas

C. Marcocci, F. Cetani, N. Pellegata, 2017, Endocrine.

HRPT2 gene analysis and the diagnosis of parathyroid carcinoma

C. Marcocci, F. Cetani, E. Vignali, 2008, Expert review of endocrinology & metabolism.

Familial hypocalciuric hypercalcemia in a woman with metastatic breast cancer: a case report of mistaken identity.

C. Marcocci, F. Cetani, A. Pinchera, 2003, The Journal of clinical endocrinology and metabolism.

A patient with MEN1 and end-stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation.

U. Boggi, E. Vasile, C. Marcocci, 2017, Molecular and clinical oncology.

The sulfaphenazole-sensitive pathway acts as a compensatory mechanism for impaired nitric oxide availability in patients with primary hyperparathyroidism. Effect of surgical treatment.

C. Marcocci, F. Cetani, A. Pinchera, 2010, The Journal of clinical endocrinology and metabolism.

Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features

C. Marcocci, F. Cetani, F. Bogazzi, 2017, PloS one.

Hypoparathyroidism due to autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy: long-term clinical follow-up

F. Cetani, R. Parrino, G. Baroncelli, 2004 .

Novel association of MEN1 gene mutations with parathyroid carcinoma

C. Marcocci, F. Cetani, E. Maiello, 2017, Oncology letters.

A nonfunctioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule

C. Marcocci, F. Cetani, F. Basolo, 2015, World Journal of Surgical Oncology.

Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment

C. Marcocci, F. Cetani, A. Pinchera, 2008, Journal of endocrinological investigation.

Normocalcemic primary hyperparathyroidism

F. Cetani, N. Cusano, 2011, Archives of endocrinology and metabolism.

Management of Primary Hyperparathyroidism

G. Guyatt, L. Rejnmark, C. Marcocci, 2022, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas

F. Cetani, A. Pinchera, R. Barsacchi, 1999, Journal of endocrinological investigation.

Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial.

C. Marcocci, F. Cetani, E. Vignali, 2007, The Journal of clinical endocrinology and metabolism.

Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women.

C. Marcocci, F. Cetani, E. Vignali, 2003, European journal of endocrinology.

Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the CYP24A1 Gene: A Case Report and Review of the Literature

C. Marcocci, F. Cetani, E. Vignali, 2019, Case reports in endocrinology.

A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis.

C. Marcocci, F. Cetani, A. Pinchera, 2001, The Journal of clinical endocrinology and metabolism.

Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

C. Marcocci, F. Cetani, E. Vignali, 2009, The Journal of clinical endocrinology and metabolism.

Thyroid ultrasonography helps to identify patients with diffuse lymphocytic thyroiditis who are prone to develop hypothyroidism.

A Pinchera, C. Marcocci, F. Cetani, 1991, The Journal of clinical endocrinology and metabolism.

Post-surgical follow-up of differentiated thyroid cancer

F. Cetani, A. Pinchera, R. Elisei, 1995, Journal of endocrinological investigation.

Late-onset postsurgical hypoparathyroidism following parathyroidectomy for recurrent primary hyperparathyroidism: a case report and literature review

C. Marcocci, F. Cetani, E. Pardi, 2020, Endocrine.

Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia

C. Marcocci, F. Cetani, A. Pinchera, 2003, Clinical endocrinology.

The thyroperoxidase doublet is not produced by alternative splicing

F. Cetani, M. Tonacchera, S. Costagliola, 1995, Molecular and Cellular Endocrinology.

Functional characteristics of a variant thyrotropin receptor.

F. Cetani, M. Tonacchera, S. Costagliola, 1996, European journal of biochemistry.

The microRNA cluster C19MC is deregulated in parathyroid tumours.

F. Cetani, V. Vaira, S. Bosari, 2012, Journal of molecular endocrinology.

A proteomic approach to study parathyroid glands.

C. Marcocci, F. Cetani, A. Pinchera, 2010, Molecular bioSystems.

Update on parathyroid carcinoma

C. Marcocci, F. Cetani, E. Pardi, 2016, Journal of Endocrinological Investigation.

Genetic analyses in familial isolated hyperparathyroidism: implication for clinical assessment and surgical management

C. Marcocci, F. Cetani, E. Vignali, 2006, Clinical endocrinology.

Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors.

F. Cetani, M. Tonacchera, S. Costagliola, 1998, The Journal of clinical endocrinology and metabolism.

A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature

C. Marcocci, F. Cetani, S. Borsari, 2020, Endocrine.

The Oncosuppressors MEN1 and CDC73 Are Involved in lncRNA Deregulation in Human Parathyroid Tumors

F. Cetani, V. Vaira, A. Scillitani, 2020, Journal of Bone and Mineral Research.

Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors.

C. Marcocci, F. Cetani, L. Torregrossa, 2019, Endocrine-related cancer.

Day case parathyroidectomy: is this the right way for the patients?

F. Cetani, G. Materazzi, F. Forfori, 2020, Gland surgery.

High-intensity focused ultrasound as an alternative to the surgical approach in primary hyperparathyroidism: A preliminary experience

C. Marcocci, F. Cetani, P. Miccoli, 2011, Journal of endocrinological investigation.

Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)

L. Rejnmark, C. Marcocci, F. Cetani, 2019, European Journal of Endocrinology.

A novel mutation in the calcium-sensing receptor in a French family with familial hypocalciuric hypercalcaemia.

F. Cetani, X. Jeunemaître, P. Lecomte, 2011, European journal of endocrinology.

Identification and functional characterization of loss-of-function mutations of the calcium-sensing receptor in four Italian kindreds with familial hypocalciuric hypercalcemia.

E. Brown, C. Marcocci, F. Cetani, 2009, European journal of endocrinology.

Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss‐of‐function mutations in the calcium‐sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation

C. Marcocci, F. Cetani, A. Pinchera, 2003, Clinical endocrinology.

MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2002, Journal of endocrinological investigation.

A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors

C. Carcassi, C. Marcocci, F. Cetani, 2004, Journal of endocrinological investigation.

Six novel MEN1 gene mutations in sporadic parathyroid tumors

C. Marcocci, F. Cetani, E. Vignali, 2000 .

A new mutation of the MEN1 gene in an italian kindred with multiple endocrine neoplasia type 1.

C. Marcocci, F. Cetani, E. Vignali, 1999, European journal of endocrinology.

A new mutation of the MEN 1 gene in an Italian kindred with multiple endocrine neoplasia type 1

C. Marcocci, F. Cetani, E. Vignali, 1999 .

Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.

C. Marcocci, F. Cetani, F. Basolo, 2013, The Journal of clinical endocrinology and metabolism.

Parathyroid Carcinoma and Adenoma Co-existing in One Patient: Case Report and Comparative Proteomic Analysis

C. Marcocci, F. Cetani, F. Ciregia, 2021, Cancer Genomics & Proteomics.

Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders

F. Cetani, A. Scillitani, D. Goltzman, 2022, European journal of endocrinology.

Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.

C. Marcocci, F. Cetani, A. Pinchera, 2007, Endocrine-related cancer.

Activating Antibodies to Calcium-Sensing Receptor In Immunotherapy-Induced Hypoparathyroidism.

C. Marcocci, F. Cetani, E. Kemp, 2020, The Journal of clinical endocrinology and metabolism.

Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.

C. Marcocci, F. Cetani, A. Pinchera, 2010, Endocrine-related cancer.

Oncogenic mutations in thyroid adenoma: methodological criteria.

F. Cetani, J. Parma, M. Tonacchera, 1996, European journal of endocrinology.

Concomitant Primary Hyperparathyroidism in Patients with Multiple Myeloma: A Possible Link?

C. Marcocci, F. Cetani, N. Giuliani, 2020, Acta Haematologica.

Microvessel density in human normal and neoplastic parathyroids

C. Marcocci, F. Cetani, G. Bevilacqua, 2006, Endocrine pathology.

Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4

C. Marcocci, F. Cetani, N. Pellegata, 2014, Endocrine connections.

Parafibromin as a tool for the diagnosis of parathyroid tumors.

C. Marcocci, F. Cetani, 2008, Advances in anatomic pathology.

Editorial: Parathyroid atypical adenomas and carcinoma: An update on clinical management

F. Cetani, L. Gianotti, 2023, Frontiers in Endocrinology.

Do patients with atypical parathyroid adenoma need a close follow-up?

C. Marcocci, F. Cetani, F. Basolo, 2021, The Journal of clinical endocrinology and metabolism.

HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy

A. Gaspari, F. Trimarchi, G. Perigli, 2018, Calcified Tissue International.

Parathyroid carcinoma: a clinical and genetic perspective.

C. Marcocci, F. Cetani, E. Pardi, 2018, Minerva endocrinologica.

TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells.

F. Cetani, A. Pinchera, L. Chiovato, 2004, European journal of endocrinology.

The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment.

C. Marcocci, F. Cetani, F. Bogazzi, 2006, European journal of endocrinology.

Mapping thyroid peroxidase epitopes using recombinant protein fragments.

R. Uibo, F. Cetani, M. Tonacchera, 1995, European journal of endocrinology.

HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy

A. Gaspari, F. Trimarchi, G. Perigli, 2018, Calcified Tissue International.

Familial and Hereditary Forms of Primary Hyperparathyroidism.

C. Marcocci, F. Cetani, S. Borsari, 2018, Frontiers of hormone research.

Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database

C. Marcocci, F. Cetani, M. Brandi, 2018, Endocrine.

Clinical profile of juvenile primary hyperparathyroidism: a prospective study

C. Marcocci, F. Cetani, M. Miccoli, 2018, Endocrine.

Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association?

F. Cetani, S. Mariotti, E. Pardi, 2012, BMC Cancer.

Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: Role of calcium‐sensing receptor polymorphisms and vitamin D deficiency

S. Giannini, L. Bonfante, A. D'Angelo, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism

C. Marcocci, F. Cetani, E. Vignali, 2016, Endocrine.

Familial parathyroid hyperplasia: Is there a place for minimally invasive surgery? Description of the first treated case

F. Cetani, P. Miccoli, P. Berti, 2005, Journal of Endocrinological Investigation.

Challenges in the Preoperative Localization of Hyperfunctioning Parathyroid Tissue in a Patient with Primary Hyperparathyroidism

C. Marcocci, F. Cetani, M. Apicella, 2022, A Case-Based Guide to Clinical Endocrinology.

The use of positron emission tomography with 11C-methionine in patients with primary hyperparathyroidism

C. Marcocci, F. Cetani, 2013, Endocrine.

Indocyanine green fluorescence and near-infrared autofluorescence may improve post-thyroidectomy parathyroid function.

F. Cetani, M. Miccoli, R. Elisei, 2022, Surgery.

Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome

C. Marcocci, F. Cetani, F. Bogazzi, 2023, Frontiers in endocrinology.

The aberrantly expressed miR-372 partly impairs sensitivity to apoptosis in parathyroid tumor cells.

F. Cetani, V. Vaira, A. Scillitani, 2018, Endocrine-related cancer.

Long-term efficacy and safety of rifampin in the treatment of a patient carrying a CYP24A1 loss-of-function variant.

C. Marcocci, F. Cetani, F. Baldinotti, 2022, The Journal of clinical endocrinology and metabolism.

Acute severe primary hyperparathyroidism: spontaneous remission after 2 years follow-up

C. Marcocci, F. Cetani, F. Ferrari, 2018, Journal of Endocrinological Investigation.

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th 17-associated cytokines

F. Cetani, T. Battelino, L. Tserel, 2010 .

Acute pancreatitis as the first manifestation in a young boy with primary hyperparathyroidism

C. Marcocci, F. Cetani, Sara Barone, 2018, Endocrine.

Parathyroid Carcinoma.

C. Marcocci, F. Cetani, E. Pardi, 2018, Frontiers of Hormone Research.

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

F. Cetani, T. Battelino, L. Tserel, 2010, The Journal of experimental medicine.

Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study.

S. Giannini, C. Marcocci, F. Cetani, 2021, Panminerva medica.

The impact of thyroidectomy on parathyroid glands: A biochemical and clinical profile

C. Marcocci, F. Cetani, E. Vignali, 2007, Journal of endocrinological investigation.

Gene expression profile in metastatic and non-metastatic parathyroid carcinoma.

C. Marcocci, F. Cetani, P. Graziano, 2020, Endocrine-related cancer.

Normocalcemic primary hyperparathyroidism

F. Cetani, N. Cusano, 2022 .

Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy

C. Marcocci, F. Cetani, E. Vignali, 2015, Endocrine connections.

Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene

C. Marcocci, F. Cetani, S. Borsari, 2017, Journal of Endocrinological Investigation.

Normocalcemic primary hyperparathyroidism

F. Cetani, N. Cusano, 2022, Archives of endocrinology and metabolism.

Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations

C. Marcocci, F. Cetani, R. Elisei, 2017, Journal of surgical oncology.

Somatostatin Analogues do not Affect Calcium Metabolism in Patients with Acromegaly and Primary Hyperparathyroidism due to MEN 1-Like Syndrome

Elena S. Di Martino, F. Cetani, G. Mariani, 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Complex Primary Hyperparathyroidism

F. Cetani, F. Saponaro, 2015 .

Six novel MEN1 gene mutations in sporadic parathyroid tumors.

C. Marcocci, F. Cetani, E. Vignali, 2000, Human Mutation.

Parathyroid expression of calcium-sensing receptor protein and in vivo parathyroid hormone-Ca(2+) set-point in patients with primary hyperparathyroidism.

F. Cetani, E. Vignali, E. Pardi, 2000, The Journal of clinical endocrinology and metabolism.

Parathyroid carcinoma.

F. Cetani, V. Nicastro, A. Scillitani, 2018, Best practice & research. Clinical endocrinology & metabolism.

Approach to the Patient With Parathyroid Carcinoma.

C. Marcocci, F. Cetani, L. Torregrossa, 2023, The Journal of clinical endocrinology and metabolism.

High doses of intravenous calcitriol in the treatment of severe secondary hyperparathyroidism.

F. Cetani, L. Fortunato, M. Morosetti, 2004, Journal of nephrology.